Matches in Wikidata for { <http://www.wikidata.org/entity/Q67503642> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q67503642 description "artículu científicu espublizáu n'agostu de 1992" @default.
- Q67503642 description "im August 1992 veröffentlichter wissenschaftlicher Artikel" @default.
- Q67503642 description "scientific article published on 01 August 1992" @default.
- Q67503642 description "wetenschappelijk artikel" @default.
- Q67503642 description "наукова стаття, опублікована в серпні 1992" @default.
- Q67503642 name "The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) periph" @default.
- Q67503642 name "The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) periph" @default.
- Q67503642 type Item @default.
- Q67503642 label "The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) periph" @default.
- Q67503642 label "The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) periph" @default.
- Q67503642 prefLabel "The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) periph" @default.
- Q67503642 prefLabel "The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) periph" @default.
- Q67503642 P1433 Q67503642-70670785-5C8B-4255-9731-4D4EF8F5D1DB @default.
- Q67503642 P1476 Q67503642-07E1E9DD-8820-41B9-B184-BC5F4C31533E @default.
- Q67503642 P304 Q67503642-048682B4-9466-4635-9E53-FD49EA327857 @default.
- Q67503642 P31 Q67503642-71AC08AE-20F3-4820-AE2C-1D1628744FD0 @default.
- Q67503642 P356 Q67503642-B9482633-BC68-46B9-B116-FB92C4390384 @default.
- Q67503642 P433 Q67503642-1E32BA4B-9D06-4FAE-AE83-B38C58206255 @default.
- Q67503642 P478 Q67503642-A1841EA9-7057-4D65-8AED-7E7A9046DEF0 @default.
- Q67503642 P577 Q67503642-C2D53AA4-73BB-4FD2-9546-7D6CF9B7AC4A @default.
- Q67503642 P698 Q67503642-AE01C580-BB75-48F2-B68A-81937CF32277 @default.
- Q67503642 P921 Q67503642-7F5594E9-6B8D-4DC7-9B8F-FAB42F97F07D @default.
- Q67503642 P356 HUM.1992.3.4-411 @default.
- Q67503642 P698 1326336 @default.
- Q67503642 P1433 Q15757580 @default.
- Q67503642 P1476 "The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) peripheral blood leukocytes in combination with recombinant interleukin-2 alone, or with recombinant interleukin-2 and recombinant alpha interferon" @default.
- Q67503642 P304 "411-430" @default.
- Q67503642 P31 Q13442814 @default.
- Q67503642 P356 "10.1089/HUM.1992.3.4-411" @default.
- Q67503642 P433 "4" @default.
- Q67503642 P478 "3" @default.
- Q67503642 P577 "1992-08-01T00:00:00Z" @default.
- Q67503642 P698 "1326336" @default.
- Q67503642 P921 Q18975855 @default.